African Countries
ZIMBABWE
Axigen’s pathway is open to explore Africa’s sizeable and the most regulated market. The South African pharmaceutical market is the largest in sub-Saharan Africa. Within the African continent, South Africa is fairly well developed and the most regulated. Owing to the formidable business potential of this territory, South Africa has become a host for the headquarters of several leading life-science companies. Axigen has the distinction of being one of the Indian Company plan to get its products registered in this market and is also planning to amongst the leading Indian company in the Zimbabwean market. With a rich portfolio of 25 products and a strong pipeline of 10 products plan to registration, we are well poised to extract the high potential offered by this market.
KENYA
Kenya is the largest producer of pharmaceutical products in the common market for Eastern and Southern Africa (COMESA) region; catering to about 50% of the region. Kenya’s prescription pharmaceuticals market is worth over $500 million. Prescription drugs account for around 78% of the market value. Kenya being the gateway to East African markets is a territory of strategic significance for Axigen. Having planning to start our marketing operations, the past couple of years have witnessed consolidation of the marketing efforts
UGANDA
Strategic selection of products encompassing a wide range of therapeutic indications has found profound acceptance by the members of medical fraternity in this country. The aim is to intensify Axigen’s focus on Gynaecology, Infertility Management, Science-based Nutritional Health, Dermatology, Gastroenterology, Pain Management and Acute care.
NIGERIA
Extending its territorial fortification to Western Africa, Axigen planning to makes successful forays into Nigeria, which by far is one of the biggest markets in West Africa. Having already plan for secured registrations for a handful of its specialized products, Axigen is all set to explore this attractive market with 30 products in pipeline.
FRENCH WEST AFRICA
Axigen planning to widespread operations in Francophone countries in Africa like Ivory Coast, Senegal, Mali, Burkina Faso, Togo, Benin, Guinea, Niger, Cameroon, Congo and Gabon. The classified distribution and marketing practices in each of these countries offer excellent opportunities and therefore, Axigen is planning significant presence in all of these markets through direct promotion to doctors and pharmacies. We have a aspires that within a short span, we will be established ourselves as a leading pharmaceutical company.